Literature DB >> 15722783

Issues in opioid management.

Donna Bloodworth1.   

Abstract

Although a universal consensus has evolved concerning the utility of opioids in cancer pain, the use of opioids for the treatment of chronic nonmalignant pain syndromes is much debated in the medical literature. Although for clinical, regulatory, and medicolegal reasons, many clinicians disagree with their use, others find them helpful, with little prevalence of abuse behaviors or intolerable adverse effects. In a review of this topic, several issues of relevance to management decisions, including efficacy, medication compliance, and safety, are evaluated. As a clinically distinct population among chronic pain sufferers, patients with arthritis-associated pain (including rheumatoid and osteoarthritis) are discussed separately. Particularly important issues with regard to prescribing decisions, including divergent goals and expectations, and factors associated with avoidance of withdrawal and addiction, are also evaluated to ensure that management of patients with nonmalignant chronic pain is optimized when opioids are considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722783

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  10 in total

1.  Life without COX 2 inhibitors: opioids can be prescribed safely in osteoarthritis.

Authors:  Colette M Reid; Jeremy Horwood
Journal:  BMJ       Date:  2006-06-17

2.  Chronic pain in Canada: have we improved our management of chronic noncancer pain?

Authors:  Aline Boulanger; Alexander J Clark; Pamela Squire; Edward Cui; G L A Horbay
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

3.  Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec.

Authors:  R E Williams; N Bosnic; C T Sweeney; A W Duncan; K B Levine; M Brogan; S F Cook
Journal:  Pain Res Manag       Date:  2008 Sep-Oct       Impact factor: 3.037

Review 4.  Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence.

Authors:  Sanjay Basu; R Douglas Bruce; Declan T Barry; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2007-01-09

5.  Dopamine D₄ receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat caudate putamen.

Authors:  Diana Suárez-Boomgaard; Belén Gago; Alejandra Valderrama-Carvajal; Ruth Roales-Buján; Kathleen Van Craenenbroeck; Jolien Duchou; Dasiel O Borroto-Escuela; José Medina-Luque; Adelaida de la Calle; Kjell Fuxe; Alicia Rivera
Journal:  Int J Mol Sci       Date:  2014-01-21       Impact factor: 5.923

6.  Using visual prompts to aid analgesia prescribing.

Authors:  Kathryn Ryland
Journal:  BMJ Qual Improv Rep       Date:  2015-12-09

Review 7.  The Therapeutic Potential of Monocyte/Macrophage Manipulation in the Treatment of Chemotherapy-Induced Painful Neuropathy.

Authors:  Karli Montague; Marzia Malcangio
Journal:  Front Mol Neurosci       Date:  2017-11-27       Impact factor: 5.639

8.  A novel interaction between CX3CR1 and CCR2 signalling in monocytes constitutes an underlying mechanism for persistent vincristine-induced pain.

Authors:  Karli Montague; Raffaele Simeoli; Joao Valente; Marzia Malcangio
Journal:  J Neuroinflammation       Date:  2018-04-06       Impact factor: 8.322

9.  Current aproach to cancer pain management: Availability and implications of different treatment options.

Authors:  Hrachya Nersesyan; Konstantin V Slavin
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

10.  Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study.

Authors:  Gabrielle Campbell; Richard Mattick; Raimondo Bruno; Briony Larance; Suzanne Nielsen; Milton Cohen; Nicholas Lintzeris; Fiona Shand; Wayne D Hall; Bianca Hoban; Chyanne Kehler; Michael Farrell; Louisa Degenhardt
Journal:  BMC Pharmacol Toxicol       Date:  2014-03-20       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.